Medications for Chronic Kidney Diseases

10 results
  • farxiga - dapagliflozin tablet, film coated

    (Dapagliflozin)
    Astrazeneca Pharmaceuticals Lp
    Farxiga is indicated for adults with chronic kidney disease, heart failure, or type 2 diabetes mellitus. It reduces risks of kidney disease progression, cardiovascular death, and heart failure hospitalization, and improves glycemic control in adults and children aged 10+ with type 2 diabetes as an adjunct to diet and exercise.
  • furoscix - furosemide injection 80 mg/ 10 ml injection

    (Furosemide Injection 80 Mg/ 10 Ml)
    Scpharmaceuticals Inc.
    Furoscix treats edema in adults and pediatric patients (43 kg+) with chronic heart failure or chronic kidney disease, including nephrotic syndrome.
  • inpefa - sotagliflozin tablet

    (Sotagliflozin)
    Lexicon Pharmaceuticals, Inc.
    INPEFA reduces the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visits in adults with heart failure, or type 2 diabetes mellitus, chronic kidney disease, and other cardiovascular risk factors.
  • jardiance - empagliflozin tablet, film coated

    (Empagliflozin)
    Boehringer Ingelheim Pharmaceuticals, Inc.
    Jardiance reduces the risk of cardiovascular death and heart failure hospitalization in adults. It also slows chronic kidney disease progression, reduces cardiovascular death in type 2 diabetes with established cardiovascular disease, and improves blood sugar control in adults and children aged 10+ with type 2 diabetes.
  • kerendia - finerenone tablet, film coated

    (Finerenone)
    Bayer Healthcare Pharmaceuticals Inc.
    Kerendia reduces risk of kidney disease progression, cardiovascular death, heart attack, and heart failure hospitalization in adults with chronic kidney disease and type 2 diabetes. Also indicated for cardiovascular death and heart failure events in adults with heart failure with preserved or mildly reduced ejection fraction (LVEF ≥ 40%).
  • nutropin aq nuspin 5- somatropin injection, solution

    (Somatropin)
    Genentech, Inc.
    Nutropin AQ NuSpin 10 is a recombinant human growth hormone for children with growth failure due to growth hormone deficiency, idiopathic short stature, Turner syndrome, or chronic kidney disease, and for adults with childhood-onset or adult-onset growth hormone deficiency.
  • ozempic - semaglutide injection, solution

    (Semaglutide)
    Novo Nordisk
    Ozempic is used alongside diet and exercise to improve blood sugar control in adults with type 2 diabetes. It also reduces the risk of heart attack, stroke, and cardiovascular death in adults with established cardiovascular disease, and slows kidney disease progression in those with chronic kidney disease.
  • renvela - sevelamer carbonate powder, for suspension

    (Sevelamer Carbonate)
    Genzyme Corporation
    Renvela (sevelamer carbonate) controls serum phosphorus in adults and children 6 years and older with chronic kidney disease (CKD) on dialysis.
  • synjardy - empagliflozin and metformin hydrochloride tablet

    (Empagliflozin And Metformin Hydrochloride)
    Boehringer Ingelheim Pharmaceuticals, Inc.
    Synjardy (empagliflozin/metformin) is indicated with diet and exercise to improve blood sugar control in adults and children 10+ with type 2 diabetes. The empagliflozin component also reduces risk of cardiovascular death, heart failure hospitalization, and kidney disease progression in adults with established cardiovascular disease, heart failure, or chronic kidney disease.
  • xphozah 10 mg - tenapanor tablet, film coated

    (Tenapanor)
    Ardelyx, Inc.
    Xphozah 10 mg reduces serum phosphorus in adults with chronic kidney disease (CKD) on dialysis, used as add-on therapy when phosphate binders are inadequate or not tolerated.